GM’s United Auto Workers health care plan will own as much as 20 percent of General MOtors Corp. stock after making concessions this week that will cut dental and vision benefits while increasing copays for some retired workers, The Detroit News reports. “The union was eligible to own up to 39 percent of GM’s equity through the independent health trust fund, called the Voluntary Employees’ Beneficiary Association, that will assume responsibility for retiree health care. But the lower than 20 percent stake could mean that the company is attempting to appease unsecured bondholders, who charged that the UAW was getting a better deal.” “Dental and vision coverage and some prescription drugs for hourly retirees (are) eliminated, including erectile dysfunction medication. Low-income retirees who previously had no co-pay must now make an $11 monthly co-pay” (Aguilar and Shepardson, 5/27). In addition to the health care cuts for employees, which mirrors many of the same cuts the UAW made with Chrysler last month, union employees will forgo cost-of-living allowances, bonuses and some holidays, The Wall Street Journal reports. GM will also offer buyouts to 60,000 more employees and will not strike before September 2015. In all, GM hopes to save $1.5 billion annually in active-worker costs, according to the article. “While the UAW billed the revised retiree trust fund agreement as necessary to GM’s survival, it will leave hundreds of thousands of retirees paying higher out-of-pocket medical expenses. For decades, these retirees paid only minor charges.” In addition, the UAW VEBA will get a $2.5 billion note, $6.5 billion preferred equity stake and a seat on the GM board in addition to 17.5 percent of GM’s shares with an option for up to 20 percent. Because the share ownership figure is lower than the before estimated 40 percent of GM’s shares, the VEBA fund will get a $585 million annual dividend to use for costs (Stoll, McCracken and King, Jr., 5/27). GM, Union Agree To Cut Retiree Health Benefits In Exchange For Stock This is part of the KHN Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Database Debuts Detailing Financial Links Between Physicians And Drug Makers This is part of the KHN Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription. Consumer advocates have pushed for years for this kind of government database in an effort to protect against physicians’ conflicts of interest, to safeguard patient care and to prevent unnecessary costs to public health programs. The New York Times: Detailing Financial Links Of Doctors And Drug MakersPharmaceutical and device makers paid doctors roughly $380 million in speaking and consulting fees, with some doctors reaping over half a million dollars each, during a five-month period last year, according to an analysis of federal data released Tuesday. Other doctors made millions of dollars in royalties from products they helped develop (Thomas, Armendariz and Cohen, 9/30).Los Angeles Times: Database Shows $3.5 Billion In Industry Ties To Doctors, HospitalsThe details published Tuesday in a new government database have been sought for years by consumer advocates and lawmakers concerned that conflicts of interest in the medical profession are jeopardizing patient care and costing taxpayer-funded health programs. This first batch of payment data covers just five months of 2013, but it shows the extensive ties medical companies have forged with doctors and academic medical centers across the country. About 546,000 U.S. physicians and 1,360 teaching hospitals received some form of compensation (Terhune, Levey and Poindexter, 9/30).Kaiser Health News: As Payments Database Debuts, Doctors Urge CautionA federal database unveiled Tuesday afternoon details 4.4 million payments from pharmaceutical and medical technology companies to doctors and teaching hospitals, sparking concerns that consumers might misinterpret the information (Luthra, 10/1).The Wall Street Journal: Doctors Net Billions From Drug FirmsThe database revealed some eye-popping totals, such as the $122.5 million paid by Roche Holding’s Genentech unit to City of Hope medical center in Duarte, Calif., as royalties on sales of several products including blockbuster cancer treatments Herceptin and Avastin. Genentech licensed patents from City of Hope based on research the medical center conducted in the early 1980s. The company said that excluding the City of Hope royalties, about 85% of the physician payments it reported to CMS were focused on drug research. City of Hope said the royalties are allocated to the inventors and to support continuing research (Loftus, 9/30).The Washington Post’s Wonkblog: You Can Now Track The Billions That Drug Companies Pay Doctors And HospitalsThanks to a bipartisan transparency initiative contained in the 2010 Affordable Care Act, the federal government has compiled a massive database of how much drug and device companies spend on consulting fees, research grants, travel, free lunches and other items worth more than $10. … The rollout of this federal database has been somewhat problematic. Records aren’t complete — about 40 percent of payments have been de-identified because of problems with the data. The Centers for Medicare and Medicaid Services, the agency publishing the database, is holding back other records that are still in dispute. It’s also been difficult to navigate the database this afternoon. But these payments will be published on a regular basis, and the quality and reliability of the information is expected to improve (Millman, 9/30).The Associated Press: Drug And Device Firms Paid $3.5B To Care ProvidersThe massive trove of information named companies and many of the recipients. Also listed were types of payments, with details down to travel destinations. Some 546,000 clinicians and 1,360 teaching hospitals received benefits. It’s part of a new initiative called Open Payments, required by President Barack Obama’s health care law. It was intended to allow patients to easily look up their own doctors online, but that functionality isn’t fully developed. In future years, the information will cover a full 12 months and will be easier to search, officials said (9/30).Reuters: Drug, Medical Device Companies Paid Billions To U.S. Physicians, Hospitals In 2013U.S. doctors and teaching hospitals received $3.5 billion from pharmaceutical companies and medical device makers in the last five months of 2013, according to the most extensive data trove on such payments ever made public. The payments, disclosed by the Centers for Medicare and Medicaid Services (CMS) on Tuesday, include consulting and speaking fees, travel, meals, entertainment and research grants. The names of the recipients of about 40 percent of the payments reported by companies were withheld because CMS had concerns about data inconsistencies. Some 546,000 individual providers including physicians, dentists and osteopaths and 1,360 teaching hospitals received 4.4 million separate payments from healthcare companies. The companies were required by President Barack Obama’s 2010 healthcare reform law to disclose to CMS by March all payments of $10 or more made from August to December 2013. Even payments that physicians requested be sent to a charity were required to be reported (Begley, 9/30). NPR: Database Flaws Cloud Sunshine On Industry Payments To DoctorsBut the database is also something else: a very limited window into the billions in industry spending. Before you dive in and search your doctor, here are five caveats to keep in mind (Ornstein, 9/30).Politico: ‘Data Dump’ Reveals Billions In Pharma Payments To Docs, HospitalsIn its first hours, the website was tortuously slow. And it was incomplete: About 40 percent of the records do not identify the recipient because CMS could not match data provided by manufacturers with existing databases (Wheaton, 10/1).Minneapolis Star-Tribune: Drug, Device Companies Paid $3.5 Billion To Doctors, HospitalsOver protests from doctors and industry, the federal government for the first time Tuesday began to detail the billions of dollars that physicians and teaching hospitals receive from companies that sell medical equipment and drugs. The newly public data cover 4.4 million payments during the last five months of 2013 that totaled $3.5 billion. Fridley’s Medtronic Inc. appeared to be the biggest payer in Minnesota, with more than $10 million in spending just from its spinal and vascular divisions. St. Jude Medical in Little Canada spent just over $3 million (Carlson and Olson, 9/30).The Wall Street Journal’s Pharmalot: Does The Open Payments Database ‘Distort’ What Docs Get For Research?The database, which is being administered by the Centers for Medicare & Medicaid Services, will initially display payments made in the last five months of 2013 and will be updated going forward. Already, though, both industry and physician groups have complained that payment data lack sufficient context for the public to understand what doctors are paid. And doctors also griped they had little time to review data. Now, a group of academics from Johns Hopkins University have raised another issue. The law requires drug makers to report the total amount of “research payments” to researchers for use in clinical trials. But the academics – three bioethicists and a professor of medicine and pharmacology – argue this stipulation creates a “distorted” image of the money that doctors may receive, because it does not break out a value assigned to medicines that companies provide for the research (Silverman, 9/30).
A doctor who took kickbacks from a Pennsylvania hospice involved in a multimillion-dollar fraud. An Ohio psychiatrist who billed for treating no-show patients. A Georgia optometrist who claimed he conducted 177 eye exams in one day. Their transgressions vary. What these doctors have in common is that each was paid by a state Medicaid health insurance program after being kicked out of another state’s Medicaid system or the federal Medicare program. That’s not supposed to happen. The Affordable Care Act, or Obamacare as it is popularly known, explicitly requires that states suspend the billing privileges of most providers who have been “terminated” or “revoked” by another state or Medicare. (Pell and Cooke, 4/29) Doctors Kicked Out Of Medicare Still Billing State Medicaid Programs Reuters’ special report analyzing state and federal data found that more than one in five doctors or health care providers of the thousands banned from billing Medicare or one state Medicaid program — usually due to an infraction — were still able to file claims under another state’s program. Several states have launched investigations based on the findings. The Philadelphia Inquirer: Medicare Coverage Will Soon Cost You More This is part of the KHN Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription. If you’re on Medicare, you know that this generous government benefit isn’t free. Coverage for some services, like physician visits and outpatient prescription drugs, requires that you pay a monthly premium. And before most claims are paid, you have to meet an annual deductible. Those costs are about to grow. (Field, 4/29) Reuters: Figuring Out Who Can Bill Medicare And Medicaid, And Who Can’t Reuters: Special Report: Banned From Medicare, Still Billing Medicaid To determine how many healthcare providers were banned from Medicare or a state Medicaid program while still allowed to bill Medicaid in another state, Reuters compared states’ lists of approved providers against lists of providers terminated by other states or Medicare on a specific date in 2014. In response to open-records requests, all states and the District of Columbia supplied approved-provider lists. Only 23 states supplied terminated-provider lists, as did the Centers for Medicare and Medicaid Services, the federal agency that administers Medicare, and the U.S. Department of Health and Human Services Office of the Inspector General. (Pell and Cooke, 4/29) In other Medicare payment news, beneficiaries may soon face an increase in premiums and fees –
In other news involving genetic research — Stat: Synthetic Human Genome Project Releases Its Draft Timeline Missteps In Genetic Profiling Sometimes Lead To ‘Devastating Consequences’ A new report warns of the “dark side” of genetic testing — including fumbles that lead to patients receiving unnecessary surgery. This is part of the KHN Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription. NPR: Gene Scans For Newborns Open Big Privacy Questions Stat: Genetic Testing Fumbles, Revealing ‘Dark Side’ Of Precision Medicine Enthusiasm for precision medicine, from the White House down to everyday physicians, is at an all-time high. But serious problems with the databases used to interpret patients’ genetic profiles can lead to “inappropriate treatment” with “devastating consequences,” researchers at the Mayo Clinic warned on Monday. Their report describes the cases of some two dozen people who had heart defibrillators surgically implanted but, it turns out, never needed them. The individuals were family members who underwent genetic testing after a young relative died of a heart syndrome. Test results indicated that they carried a mutation in a heart-related gene — and the database that the testing company used indicated it caused a potentially fatal disorder. (Begley, 10/31) The research group behind an effort to synthesize a human genome this week released more information about its plans, including a draft white paper with a timeline of how the research might go. It’s the latest step in the ambitious project, originally named “Human Genome Project-Write,” which came to light after a May meeting to discuss the building of large genomes from off-the-shelf parts. Within a year, the international group will select one small-scale research project to kick off the effort, and start a “major effort to engage with representative members of the public,” according to the draft road map. By year five, it will “shift into high gear” and start tackling the creation of entire genomes — maybe human or maybe not, depending on feedback. (Swetlitz, 10/28) Just about every day, genetic counselor Shawn Fayer heads to the maternity ward at Brigham and Women’s Hospital in Boston and tries to convince new parents to give him a blood sample. Fayer is offering gene sequencing for newborns. It gives parents a tantalizing look at their baby’s genetic information. (Harris, 10/31)
A new $75 million venture capital fund is being launched to develop early-stage fintech companies and artificial intelligence applications for financial services with the backing of large financial institutions including the Caisse de dépôt et placement du Québec and Sun Life Financial.Additional partners in Luge Capital include Desjardins Group, the Fonds de Solidarité FTQ, and La Capitale, and the fund could be increased to as much as $100 million in the coming months.Luge Capital, named for the winter sport that involves hurtling down an icy course at high speed, will concentrate on seed and Series A financing. Initial investments will be between $250,000 and $2 million.“The fund will support the development of innovative solutions that improve customer experiences, enhance efficiency for financial institutions, and implement data-driven methods and artificial intelligence for decision-making,” the partners said in a statement Monday.Luge is expected to tap its financial backers for more than just money in the development their products and services.“Our AI and data-driven companies will have the opportunity to partner with our investors to access key insights in order to build best-of-breed solutions,” said David Nault, co-founder and general partner in Luge’s Montreal office.Nault, who has more than 20 years of entrepreneurial and investing experience, will lead the Montreal office. Karim Gillani, who has extensive experience in fintech, will run an office based in Toronto.“We are looking for young mission-driven companies that challenge how the world interacts with financial services,” Gillani said.The initial $50 million of capital was raised and announced by the Caisse and Desjardins last October.“There is a booming startup ecosystem in this sector,” said Guy Cormier, chief executive of Desjardins, adding that the financial institution “wants to support and help develop this incredibly exciting industry.”The backers of Luge are not the first traditional financial services firms to back a venture fund dedicated to developing the financial technology-backed products and services that are disrupting the industry.The Desmarais family behind Montreal-based Power Corp. launched Diagram last year with 50 individual “angel” investors to fund entrepreneur-driven fintech startups. The fund raised an initial $25-million, with a substantial tranche coming from the family’s investment vehicle Portag3, which has been instrumental in the funding of robo-advisor Wealthsimple since 2015.Other investments were made in online lender Borrowell, and Koho, a mobile payments and banking startup.The increasing number of partnerships and funding arrangements suggest fintechs pose less of a threat to the healthy margins of traditional financial institutions than they were assumed to in their earliest days.Recent research suggests that disruption of business models and customer loyalty may come instead from “platform” players such as Google and Amazon.Last October, global consultant McKinsey & Company said 73 per cent of U.S. millennials would be more excited by a new financial services product or service from Google, Amazon, Paypal, or Square than from their bank. One in three said they believed they would not need a bank at all. Facebook Comment June 11, 201812:02 AM EDTLast UpdatedJune 11, 201812:02 AM EDT Filed under News FP Street Join the conversation → Barbara Shecter Twitter What you need to know about passing the family cottage to the next generation 0 Comments Sponsored By: Caisse, Sun Life backing new $75 million fintech venture capital fund Additional partners in Luge Capital include Desjardins Group, the Fonds de Solidarité FTQ, and La Capitale, and the fund could be increased to $100 million Recommended For YouBWX Technologies, Inc. to Webcast Discussion of its Second Quarter 2019 ResultsNetflix shares sink 11%, analysts still see growthEuro and bond yields fall on report that ECB might amend inflation goalClimate fears lift Greens’ chances of running GermanyNorway’s Aker Energy IPO may be in late 2019 or 2020 -Aker CEO The Caisse de dépôt et placement du Québec and Sun Life Financial are backing a venture capital fund to develop artificial intelligence applications for financial services.Ryan Remiorz/The Canadian Press Share this storyCaisse, Sun Life backing new $75 million fintech venture capital fund Tumblr Pinterest Google+ LinkedIn Featured Stories advertisement ← Previous Next → Reddit More Email
It’s an exciting time for electric scooters and mopeds. The number of manufacturers continues to grow, and that competition is also keeping prices affordable.SWAG isn’t the newest electric scooter company, as they’ve already been selling their products in Asia for years. But they are the newest electric scooter company to begin selling worldwide. And with a price tag of $1,200, it’s hard not to at least take a second look at these cute little EVs. more…The post These new $1,200 Bosch-powered 35 mph city electric scooters are going global appeared first on Electrek. Source: Charge Forward
Above: GM’s critically-acclaimed design aesthetic for its Volt concept car, shown at 2007’s Detroit Auto Show, never made it to production (Image: Ultimate Car Page)Indeed, one glaring issue is that Big Auto releases lackluster designs for their electric cars. Diarmuid O’Connell, Tesla’s former VP of business development once explained that legacy automakers have “delivered little more than appliances. Now, appliances are useful. But… they tend to be unemotional.” Tesla CEO, Elon Musk, goes one step further, pointing out that an electric car shouldn’t “feel like a weird-mobile.” Big Auto Following Tesla’s Lead Beyond Just The Cars HEDGE FUND MANAGER: BIG AUTO’S ELECTRIC CARS ARE ‘BLAH’ COMPARED TO TESLABrad Cornell teaches financial economics at Caltech. He also happens to manage a hedge fund. And when it comes to Tesla, he’s by no means a bull. He still believes Tesla is overvalued. However, much like short seller Andrew Left, he’s becoming disillusioned with EV efforts from legacy automakers.*This article comes to us courtesy of EVANNEX (which also makes aftermarket Tesla accessories). Authored by Matt Pressman. The opinions expressed in these articles are not necessarily our own at InsideEVs.Check Out These Stories: Source: Electric Vehicle News Above: BMW i3 and Renault Zoe (Image: Avto Magazin)According to Cornell, “When I see a Chevy Bolt, or a BWM i3, or a Nissan Leaf, or basically any electric car other than Tesla my reaction is – blah. And sales figures demonstrate I am not alone. Apparently, people feel morally good about driving one of the Tesla competitors, but they don’t actually feel good. Only Tesla had the design, the pizzazz and the performance to make driving special and not a chore.” Above: Teslas are imbued with a different electric vehicle design sensibility than what we’ve seen from legacy carmakers (Image: Tesla)Granted, Jaguar’s I-Pace deserves kudos for beating Das Auto to market. Audi is celebrating its e-tron at high-profile parties. And electrified concept cars are often front-and-center at auto shows. But right now, Cornell notes, “If you want a fun, cool, sexy, tech looking ride the choice is Tesla – period. And that is what my valuation models missed. The stock may still be overpriced, but how much depends on how quickly real competition emerges.” And he concludes, “It has not been emerging very quickly.”===Source: Valuewalk (via Brad Cornell) Above: Daimler’s Smart electric cars (Image: Cars Guide)Cornell admits, “My mistake in 2014 was thinking that competition for Tesla was just around the corner. Now, at the end of 2018, it is still just around the corner. Although Jaguar has been promising the iPace for some time, my visits to dealers have been rewarded only with promises. The same is true for the Porsche Taycan… there is not a meaningful Tesla competitor available today or in the near future.” Above: Chevy Bolt and Nissan Leaf (Image: Mike Suding)Cornell did a U-turn on Tesla. Why? He explains (via Valuewalk), “One thing I did not evaluate accurately when I began constructing valuation models for Tesla in early 2014 was how slow the competition would be to produce electric cars that people would want to drive. Tesla competitors, to the extent that any appeared, seemed to be saying that the point of an electric car was to be green and efficient, not sexy or exciting.” Big Auto Still Spends Big Dollars Promoting Gas Cars, Not Tesla Killers Do Legacy Automakers Have True Motivation To Bury Tesla? Author Liberty Access TechnologiesPosted on November 5, 2018Categories Electric Vehicle News
Tesla Model S, X Hold Higher Resale Value Than Rivals Author Liberty Access TechnologiesPosted on January 1, 2019Categories Electric Vehicle News Larry Dixon of J.D. Power says price increases “quite extraordinary.”For years, electric vehicles have had relatively low resale value for a variety of reasons. Used electric vehicles are typically priced with the $7500 federal tax credit baked in. The plug-in market is also rapidly improving. First gen electrics such as the Chevy Spark EV and 2015 Nissan LEAF simply cannot compare to the Chevy Bolt EV and the Gen 2 LEAF. Not to mention the sales success of the year: the Tesla Model 3.More About Electric Vehicle Resale Value KBB: 2014 Honda Accord PHEV Grabs Best Resale Value Title for Plug-In Vehicles Source: Electric Vehicle News Resale Values For Electric Cars Continue To Drop – Not For Teslas Though But depreciation on these older models appears to be turning around. According to Black Book’s three-year retention gauge, the value of used EVs this year is about 38%. That is a large improvement from from only 21% one year ago.J.D. Power and Associates has found that the 2015 Nissan Leaf is now retaining 30% of its original sticker price. That is up 23% from the fourth quarter last year. Wholesale prices of the 2015 LEAF are up about 1 percent from where they were last year.“Now we have prices up for the first time ever.” Says Larry Dixon, senior director of valuation services at J.D. Power. “So from a consumer standpoint, that means they have an appreciating asset.”Other first gen electric vehicles are seeing similar results. The Fiat 500e is retaining 21%, up from 18% last year. The Chevy Spark EV is retaining 25% this quarter compared to 21% from last year. Spark EV wholesale value is up 10% year over year.In the case of the Nissan LEAF, Dixon believes prices have reached rock bottom. The value of compact cars are similarly up this year. But he says automakers and some dealers are getting better at understanding the demand for these vehicles.Due to increased production, it might seem reasonable to assume that used values would continue to drop. However, this is being offset by growing consumer awareness of electric vehicles.As any EV advocate will tell you: ‘Butts In Seats’ is a key demand generator.“Based on what we’ve seen this year and starting in the latter half of last year, there’s clearly some consumer demand.”Source: Automotive News
De-ICEing experiment.When a non-electric car (ICE) is blocking a charging spot, thus preventing EVs from recharging, it’s called being ICEd. Sometimes it’s accidental. Often times it’s intentional.Tesla Trip recently did a De-ICEing experiment with Chevy Silverado truck parked along several Tesla Superchargers. By towing it a bit with a Tesla Model X, which is capable of towing.See Also Source: Electric Vehicle News Hawaii Cracking Down on Electric Vehicle Parking Violators Washington State Governor Signs Into Law $124 Fine for ICE Drivers Who Illegally Park in EV Only Spaces The experiment – with their own pickup truck – is kind of a proof of concept and, at least on snow, it seems to be technically doable.However, especially in case of purposely parked ICE cars, we can’t advise towing the cars from charging spot because several; things could go wrong – from the legal and safety perspective (damage to the cars, lawsuit, street fight, etc.).We must also remember that there is a problem with EVs being left at the DC fast charger, while already fully or almost fully charged (low charging speeds).One of many real-life examples of these trucks purposely blocking charging stations can be found here:Angry Truck Owners Are Blocking #Tesla Supercharger Spots. The EV vs. ICE wars have begun. #electriccar #truck Read: https://t.co/ZqjZT536Kg pic.twitter.com/8x76EQE6Sn— CarBuzz (@CarBuzzcom) December 25, 2018 Author Liberty Access TechnologiesPosted on January 2, 2019Categories Electric Vehicle News Fully Charged Features The “Being ICE’d” Phenomenon – Video
It may seem like a conventional ICE-powered vehicle but underneath the skin should be a compact plug-in hybrid powertrain consisting of a 1.5-liter gasoline engine and an electric motor. This system should be good for a purely electric range of about 50 miles (80 kilometers) on a single charge of the batteries before the gas engine kicks in.Alternatively, depending on the market, the Lynk & Co 4 is expected to be offered with a 2.0-liter turbodiesel in versions with 150 hp (112 kW) and 190 hp (142 kW). At launch, a 250-hp (186 kW) gasoline unit will also be available, which will be joined by a smaller 180-hp (134 kW), 1.5-liter engine later during the model’s lifecycle.Photos: Automedia According to unconfirmed information, the model will be based on the architecture that will also underpin Volvo’s upcoming revamped 40 series of compact cars. The Swedish hatch and small wagon are rumored to go fully electric, but that won’t be the case with Lynk & Co’s sibling. Porsche Taycan Sport Turismo Wagon Spied For First Time Author Liberty Access TechnologiesPosted on January 16, 2019Categories Electric Vehicle News 2020 Honda Urban EV Spied Testing: Still Looks Adorable 2020 Mercedes-Benz GLE PHEV Spied Lapping Nurburgring: Video Source: Electric Vehicle News It’s China’s answer to the Ford Focus and VW Golf.Lynk & Co is progressing with the development of its fourth model which will take the shape of a compact hatchback. This fresh batch of spy photos reveals the company is in the advanced stages of testing as its prototype is featuring less and less camouflage.More Spy Shots The previous time we saw the Lynk & Co 4 during tests, it was out on public roads under heavy disguise. This time around, most of the plastic body panels are gone and the trial car is showing its production headlights and taillights more generously. You don’t have to be a car guru to recognize the brand’s now familiar design language with two rows of lights at the front and a muscular side profile.
There’s no denying that mainstream media coverage surrounding Tesla is incredibly negative. But why?Source: Electric Vehicle News
Tottenham Hotspur news Tottenham Hotspur Roman Pavlyuchenko is close to completing a £12m transfer to Tottenham Hotspur. The Spartak Moscow striker withdrew from his club’s squad to face Dynamo Kiev in the Champions League qualifying round tonight and spoke of his excitement at the impending move.”I can confirm I’m joining [Tottenham],” he said. “Right now I’m getting my visa and as soon as it is ready I will fly to England to sign a contract. I won’t play in Kiev. Everything has happened very quickly so I couldn’t even say goodbye to my team-mates.”Pavlyuchenko’s comments to Russian media came at the end of a whirlwind day. Earlier he had been quoted as saying that he would not join Tottenham, having already suggested that for family reasons he wanted to remain in Moscow.”I could not decide if I wanted to go to England at first – first yes, then no,” he said. “The only thing that stopped me from leaving was my family. But now all doubts are behind me and I decided to sign a contract with Tottenham and the formalities are practically settled.”Tottenham have long held an interest in the Russia international, who came to wider prominence with the goals that secured a 2-1 victory over England in qualifying for Euro 2008.”There is a concrete sum which Tottenham proposed and we have agreed the amount,” said Spartak’s general manager, Valery Karpin. “If Roman will agree a contract then we are ready to let him go.Pavlyuchenko, 26, who scored three goals as Russia reached the semi-final of Euro 2008, may not be the last arrival at White Hart Lane before next Monday night’s transfer deadline, with Spurs short of attacking options after Robbie Keane’s move to Liverpool. Darren Bent was the only striker in the squad for Saturday’s 2-1 defeat by Sunderland, and Dimitar Berbatov remains in limbo.The move for Pavlyuchenko is independent of the Berbatov situation. The Bulgarian trained yesterday with the Tottenham first team, having been dropped from the squad for Saturday’s game, but he is desperate for the club to sanction his move to Manchester United.Shaun Wright-Phillips has been given the choice of reviving his career at Manchester City or Everton after being told his first-team chances would remain limited at Chelsea under Luiz Felipe Scolari. City are believed to have offered almost £10m for the winger they sold to Chelsea for £21m in 2005, whereas Everton have proposed a one-year loan deal with a view to a permanent move next summer.Everton yesterday secured their first new arrival of the summer when the Denmark right-back Lars Jacobsen completed a free transfer. They are expecting a decision from Rennes today on their latest offer for Stéphane M’Bia. The Cameroon international midfielder has been a target for David Moyes all summer but Rennes have so far not lowered their £10m valuation of the 22-year-old. David Hytner and Andy Hunter Share on Twitter Spartak Moscow Share on Facebook Roman Pavlyuchenko scored three goals during Russia’s Euro 2008 campaign. Photograph: Alex Livesey/Getty Share on Pinterest Tue 26 Aug 2008 19.34 EDT First published on Tue 26 Aug 2008 19.34 EDT I’m going to join Tottenham, says Pavlyuchenko Premier League 2008-09 This article is more than 10 years old Share via Email Share on Messenger Share on WhatsApp This article is more than 10 years old Share on Facebook Share on Twitter Premier League Topics Share via Email Share on LinkedIn Shares00 Reuse this content
PRIVATE BLOG – The Interest Rate Nonsense Private blog posts are exclusively available to Socrates subscribers. To sign-up for Socrates or to learn more, please visit Ask-Socrates.com.https://ask-socrates.com/ « Will Social Security Exist in 2021? Categories: Interest Rates
This bird might look like a holiday ornament, but it is actually a rare half-female, half-male northern cardinal (Cardinalis cardinalis, pictured with female plumage on the left and male plumage on the right) spotted a few years ago in Rock Island, Illinois. Researchers have long known such split-sex “gynandromorphs” exist in insects, crustaceans, and birds. But scientists rarely get to extensively study a gynandromorph in the wild; most published observations cover just a day or so. Observers got to follow this bird, however, for more than 40 days between December 2008 and March 2010. They documented how it interacted with other birds and even how it responded to recorded calls. The results suggest being half-and-half carries consequences: The cardinal didn’t appear to have a mate, and observers never heard it sing, the researchers report this month in The Wilson Journal of Ornithology. On the other hand, it wasn’t “subjected to any unusual agonistic behaviors from other cardinals,” according to the paper. Intriguingly, another gynandromorph cardinal sighted briefly in 1969 had the opposite plumage, they note: the male’s bright red plumes on the right, the drabber female feathers on the left.
Ray Charles, a much loved and respected musical genius, had a long career as a musician that was almost cut short by his heroin addiction. In November of 1961, the singer was arrested at the Sheraton-Lincoln Hotel in downtown Indianapolis, Indiana.Shortly after he checked in, he received a call from a man wanting to sell him drugs. When the man arrived, Charles bought a dozen three dollar capsules filled with heroin.Ray Charles. Photo by Mallory1180 CC BY-SA 4.0He and his band traveled to Anderson, Indiana just northeast of Indianapolis for a concert the next day, and returned to Indianapolis.The plan was to go to a local club to hear Aretha Franklin sing, but Charles stayed behind.Photo of Ray Charles in one of his classic poses at the piano.The next morning a knock on the door of his suite woke Charles and when he asked who was at the door the reply was “Western Union” — but in fact, it was the Indianapolis police.They pushed their way in without a search warrant and searched the room with Charles not knowing what was happening.Ray Charles exiting the stageThey seemed to know just where to look and found a needle and ten of the heroin capsules empty with residue still remaining.Ray was arrested and hustled out the door with no respect for his privacy.Ray Charles in Hamburg, 1971. Photo by Heinrich Klaffs CC BY SA 2.0He was taken to the police station where the press was clamoring for a story, and the police staff let them into the room.Although Charles was blind, he knew the familiar sound of camera shutters being clicked.Trade ad for Ray Charles’ single “Yesterday.”The reporters crowded around him and fired off embarrassing questions reducing the singer to tears.The next day Charles was released on bond and headed to his hotel to meet up with his band, who had heard of the arrest on the radio.Charles at the North Sea Jazz Festival, 1983.They left for a gig in Evansville, Indiana across the Ohio River from the border of Kentucky.When they arrived, the group was met by reporters who, again, encircled Charles pressing him with ridiculous questions.Ray Charles at Grammy Awards – rehearsal – February, 1990. Photo by Alan Light CC By 2.0When Charles returned to Indianapolis for his court appearance, a media circus greeted him at the courthouse.They caused such a commotion that Judge Ernie S. Burke threatened to clear the building.He set the date of the trial for January 1962. Charles posted his $1,000 bail bond and left Indiana for Nashville, Tennessee.Charles meeting with President Richard Nixon, 1972. Photo by Oliver F. AtkinsThe concert tour was dogged by reporters who would not leave him alone. Repercussions of the arrest included a cancellation of an appearance on the Ed Sullivan television show, a venue that introduced many fledgling stars to the public including Elvis Presley, the Beatles and the Rolling Stones. Several other concerts were canceled as well.Ray Charles’ microphone. Photo by Andrew Russeth CC BY-SA 2.0In January, Charles returned to Indianapolis for his trial at the courthouse which was packed with reporters and fans.The judge heard his attorney’s arguments that the police entered under false pretenses and illegally searched the room.Charles with President Ronald Reagan and First Lady Nancy Reagan, 1984.Judge Burke set his response for three weeks later when he ruled that because of the illegal way the police tried to entrap Charles, the charges would be dismissed.For many, the fiasco would have caused them to think twice about returning to drugs but the pull of addiction was too strong for Charles and he was arrested for heroin possession again in 1964.Ray Charles monument in Montreux, Switzerland. Photo by Lysippos CC BY-SA 3.0Wisely, Charles checked himself into St. Francis Hospital in Lynwood, California for addiction treatment.After about five months in the hospital he emerged addiction free and was put on probation for five years. By 1966, his songs were climbing the music charts again.Star honoring Ray Charles on the Hollywood Walk of Fame, at 6777 Hollywood Boulevard.Ray Charles, whose real surname was Robinson, died from liver disease in 2004 at the age of seventy three, in Beverly Hills, California.He was entombed at Inglewood Park Cemetery in Los Angeles, California.Over one thousand people attended his funeral at the First African Methodist Episcopal Church. Some of his most beloved songs were performed at the service by Wynton Marsalis, Stevie Wonder, B.B. King, Willie Nelson, his longtime chess partner and songwriting collaborator and his son, the Rev. Robert Robinson Sr.Read another story from us: Ozzy Osbourne Bit the Head Off a Live Bat and Snorted a Line of AntsDuring his lifetime Ray Charles won twelve Grammy Awards and according to biography.com he performed more than ten thousand concerts and put out over sixty records.